Study data indicate that women who ate a Western diet also had 46 percent higher risk of breast cancer.
The definition of dense breasts can range from 6.3 to 84.5 percent of patients, depending on radiologist.
Both automated and clinical assessments of breast density are associated with breast cancer risk.
Diabetes treatments, such as diet or pills (eg, metformin), decrease mammographic density, whereas insulin may increase mammographic density.
Breast density assessments can vary for as many as 19% of women, which can lead to inconsistent information regarding the need for additional clinical screenings.
Not all women with dense breasts have a high enough breast cancer risk to justify additional imaging after a normal mammogram, according to a recent study.
Five-year risk plus breast density can best identify women at high risk for interval cancer.
Lowest variability seen in Volpara and Quantra; higher variability for Cumulus ABD and CumulusV methods.
A low degree of mammographic breast density worsens the prognosis of breast cancer, according to a recent study.
Disparities exist regarding the level of awareness and knowledge of breast density among US women, according to a study.
Half of primary care physicians are still unfamiliar with the California law mandating that clinicians notify women with dense breast tissue, and many do not feel comfortable answering breast density-related questions.
Semiautomated computer-derived measurements are consistent with radiologist assessments, according to a study.
Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research.
Mammographic density is associated with breast cancer among women younger than 50 years, according to a study.
A website has been developed to help navigate the new challenges posed by breast-density notification laws, according to a recent special report.
HRT-linked risk up for white, Asian, Hispanic women; for low/normal BMI and dense breasts.
For women treated with tamoxifen, decrease in mammographic density tied to improved survival.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer
- Smoking-related Cancer Deaths Highest in Southern United States
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|